INSIGHTS ON DRUG DEVELOPMENT
-
High-Dose Delivery: Integration And Performance
High-viscosity therapies bring new delivery challenges. Explore how needle, syringe, and device design affect injection performance, reliability, and user experience.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
-
Questions That Will Accelerate The Speed Of Your Program To Clinical
The right early-stage strategy can prevent costly delays later. Explore key considerations for advancing programs to the clinic with confidence.
-
Why Controlled Release Is Essential For Patient-centric Drug Development
Controlled release design can ease daily dosing burden by moderating swings in drug exposure, though the right approach depends on API properties and what manufacturing can deliver at scale.
-
Flying On Two Wings: Balancing Local Agility And Global Quality In China8/12/2026
As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow11/7/2025
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
Moving Faster, With Confidence: Interview With Ulrike Bauer10/15/2026
What helps programs advance from development to commercial scale? Ulrike Bauer explores the role of platform flexibility, device readiness and tailored support. Watch now.
-
Development Of Scalable Purification For Biotherapeutic Peptides8/26/2025
Discover key strategies for reversed-phase isolation of biotherapeutic peptides, as well as learn about method development, scale-up techniques, and RP/MS analysis to enhance purification workflows.
-
Navigating Complexity: Tailored Analytical & Preclinical Services2/26/2026
Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.
DRUG DEVELOPMENT SOLUTIONS
-
Custom microscopy workstations to meet your advanced imaging needs.
-
The ACQUITY Premier Solution enables your lab to make informed decisions and reduce risk with stronger analytical capabilities to detect more of your sample components from the very beginning.
-
Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.
With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.
-
Our combined method development experience ensures that client methods are robust, effective, flexible, innovative and allow true stability indication.
-
Learn more about important considerations in peptides and SEC column separation and a SEC column technology solution.